Sioux Falls-based SAB Biotherapeutics has received an additional $35.6 million in government funding, plus $14 million in series B funding that includes a new investor – global health care leader Merck.
This team takes on the tough but valuable work of helping organizations fundraise – with impressive results.
A new study from Sanford Research will try to determine the prevalence of COVID-19 and learn more about its antibodies.
The USD Discovery District’s leader is taking steps to achieve a vision he says can make Sioux Falls “the next pharmaceutical and bioscience hub in the country.”
Sioux Falls-based Raven Industries will help the federal government provide medical supplies to support the pandemic response.
COVID-19 couldn’t kill their entrepreneurship dreams: How startups are making it work despite launching during the pandemic.
The co-working and networking space known as The Kitchen is closing.
From homegrown biotech companies to large organizations that might be looking for new locations, there are numerous opportunities to grow the bioscience industry in South Dakota following the pandemic.
From a big national honor to research related to COVID-19, a lot has been happening at this Sioux Falls biotech firm.
Sioux Falls-based SAB Biotherapeutics has confirmed that its treatment in development specifically for the virus that causes COVID-19 has produced antibodies that neutralized the virus in a way that’s four times as potent as using plasma from recovered patients.
